High Response Rates in Platinum-Resistant Ovarian Cancer With Immunotherapy Agents

(MedPage Today) -- SAN JUAN, Puerto Rico -- Two inhibitors of the same immune checkpoint family produced high response rates and evidence of durability in preliminary studies of advanced gynecologic cancers. Patients with platinum-resistant...
Source
MedPage Today
Opens original article in a new tab



